Variable | Over all (n = 180) | HIV (n = 137) | HIV+/HBV+/ HCV (n = 43) | p value |
Age (year) | 44.2 ± 11.0 | 44.6 ± 10.6 | 42.8 ± 12.2 | 0.369 |
<40% | 33.3 | 29.9 | 44.2 | 0.132 |
40% - 49% | 34.4 | 38.0 | 23.3 |
|
≥50% | 32.2 | 32.1 | 32.6 |
|
Gender, % |
|
|
| 0.416 |
Female | 76.7 | 78.1 | 72.1 |
|
Male | 23.3 | 21.9 | 27.9 |
|
Transfusion, % | 32.8 | 33.6 | 30.2 | 0.684 |
Pedicure and manicure, % | 46.7 | 51.1 | 32.6 | 0.034 |
Jaundice in the past, % | 5.6 | 5.1 | 7.0 | 0.704 |
Concept of anti-HBV vaccination, % | 1.1 | 1.5 | 0.0 | - |
Scarification, piercing, excision, % | 40.0 | 39.4 | 41.9 | 0.775 |
Substance addiction, % | 6.7 | 5.1 | 11.6 | 0.161 |
Number of sexual partners, % |
|
|
| 0.125 |
1 | 61.1 | 64.2 | 51.2 |
|
>1 | 38.9 | 35.8 | 48.8 |
|
Condom use, % | 20.0 | 21.2 | 16.3 | 0.484 |
Surgery in the past, % | 45.0 | 43.8 | 48.8 | 0.562 |
Knowledge of status | 1.1 | 0.7 | 2.3 | 0.424 |
Duration of HIV infection (years) | 3 (1 - 20) | 4 (1 - 15) | 2 (1 - 20) | 0.022 |
Clinical stage of HIV, % |
|
|
| 0.194 |
I | 10.0 | 8.0 | 16.3 |
|
II | 30.6 | 28.5 | 37.2 |
|
III | 46.1 | 49.6 | 34.9 |
|
IV | 13.3 | 13.9 | 11.6 |
|